Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-27 6:17 pm Sale |
2024-11-18 | 13D | Syros Pharmaceuticals, Inc. SYRS |
Samsara BioCapital, L.P. | 707,114 2.600% |
-1,808,409 (-71.89%) |
Filing History |
| 2025-02-14 4:09 pm Sale |
2024-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Point72 Asset Management, L.P. | 496 0.000% |
-1,471,275 (-99.97%) |
Filing History |
| 2025-02-14 10:10 am Sale |
2024-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Avidity Partners Management LP | 2,048,020 7.600% |
-809,553 (-28.33%) |
Filing History |
| 2025-02-14 08:41 am Sale |
2024-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Deep Track Capital, LP | 0 0.000% |
-699,281 (Position Closed) |
Filing History |
| 2025-02-12 4:30 pm Sale |
2024-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Invus Public Equities, L.P. | 1,063,829 3.800% |
-2,587,372 (-70.86%) |
Filing History |
| 2025-02-12 09:41 am Sale |
2024-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
ADAGE CAPITAL PARTNERS GP LLC | 531,914 1.980% |
-2,092,070 (-79.73%) |
Filing History |
| 2024-11-14 5:28 pm Purchase |
2024-09-30 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Avidity Partners Management LP | 2,857,573 9.900% |
195,367 (+7.34%) |
Filing History |
| 2024-11-14 5:24 pm Purchase |
2024-09-30 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Bain Capital Life Sciences Fund II, L.P. | 2,750,151 11.000% |
343 (+0.01%) |
Filing History |
| 2024-11-14 5:05 pm Sale |
2024-09-30 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Blue Owl Capital Holdings LP | 515,855 1.920% |
-977,397 (-65.45%) |
Filing History |
| 2024-11-12 4:30 pm Purchase |
2024-09-30 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Invus Public Equities, L.P. | 3,651,201 9.900% |
82,359 (+2.31%) |
Filing History |
| 2024-08-02 6:39 pm Purchase |
2024-07-25 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Invus Public Equities, L.P. | 3,568,842 9.900% |
3,568,842 (New Position) |
Filing History |
| 2024-02-14 8:56 pm Purchase |
2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Blue Owl Capital Holdings LP | 1,493,252 5.740% |
1,493,252 (New Position) |
Filing History |
| 2024-02-13 8:22 pm Purchase |
2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Avidity Partners Management LP | 2,662,206 9.900% |
472,487 (+21.58%) |
Filing History |
| 2024-02-13 7:02 pm Sale |
2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Ally Bridge MedAlpha Master Fund L.P. | 570,976 2.600% |
-868,403 (-60.33%) |
Filing History |
| 2024-02-13 6:59 pm Purchase |
2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Bain Capital Life Sciences Fund II, L.P. | 2,749,808 11.000% |
625,114 (+29.42%) |
Filing History |
| 2024-02-09 5:08 pm Purchase |
2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Artal Participations S.a r.l | 3,568,842 9.900% |
2,105,013 (+143.80%) |
Filing History |
| 2024-02-07 07:09 am Purchase |
2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
ADAGE CAPITAL PARTNERS GP LLC | 2,623,984 9.990% |
1,370,156 (+109.28%) |
Filing History |
| 2024-01-02 4:15 pm Purchase |
2023-12-21 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Point72 Asset Management, L.P. | 1,471,771 5.700% |
1,471,771 (New Position) |
Filing History |
| 2023-12-26 5:19 pm Purchase |
2023-12-21 | 13D | Syros Pharmaceuticals, Inc. SYRS |
Samsara BioCapital, L.P. | 2,515,523 9.500% |
909,977 (+56.68%) |
Filing History |
| 2023-10-20 4:15 pm Purchase |
2023-01-15 | 13D | Syros Pharmaceuticals, Inc. SYRS |
Samsara BioCapital, L.P. | 1,605,546 7.500% |
1,605,546 (New Position) |
Filing History |